Pharmaceutical involvement in phase II breast cancer clinical trials

被引：1
|
作者：
Schneider, A.
Zhang, T.
Kamal, A.
Patel, K.
Hamilton, E. P.
Peppercorn, J. M.
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.6104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6104
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Application of predictive probability in phase II cancer clinical trials
    Lee, JJ
    Liu, DD
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 224S - 224S
  • [22] Bayesian interim analysis of phase II cancer clinical trials
    Heitjan, DF
    STATISTICS IN MEDICINE, 1997, 16 (16) : 1791 - 1802
  • [23] Docetaxel in patients with metastatic breast cancer: A phase II study of the National Cancer Institute of Canada - Clinical Trials Group
    Trudeau, ME
    Eisenhauer, EA
    Higgins, BP
    Letendre, F
    Lofters, WS
    Norris, BD
    Vandenberg, TA
    Delorme, F
    Muldal, AM
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 422 - 428
  • [24] 'Triple negative' breast cancer: a new area for phase III breast cancer clinical trials
    Kilburn, L. S.
    CLINICAL ONCOLOGY, 2008, 20 (01) : 35 - 39
  • [25] Outcomes in phase II trials of metastatic breast cancer: Where is the bar?
    Kamal, A.
    Zhang, T.
    Schneider, A.
    Patel, K.
    Hamilton, E. P.
    Marcom, P. K.
    Peppercorn, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Prevalence and impact of correlative science in breast cancer phase II trials
    Zhang, T.
    Hamilton, E. P.
    Schneider, A.
    Patel, K.
    Kamal, A.
    Peppercorn, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Docetaxel for Metastatic Breast Cancer: Two Consecutive Phase II Trials
    Campora, Elisabetta
    Colloca, Giuseppe
    Ratti, Riccardo
    Addamo, Gianfranco
    Coccorullo, Zaira
    Venturino, Antonella
    Guarneri, Domenico
    ANTICANCER RESEARCH, 2008, 28 (6B) : 3993 - 3995
  • [28] Prevalence and impact of correlative science in breast cancer phase II trials
    Tian Zhang
    Andrew Schneider
    Erika P. Hamilton
    Krish Patel
    Arif H. Kamal
    Gary H. Lyman
    Jeffrey M. Peppercorn
    Breast Cancer Research and Treatment, 2013, 139 : 845 - 850
  • [29] Prevalence and impact of correlative science in breast cancer phase II trials
    Zhang, Tian
    Schneider, Andrew
    Hamilton, Erika P.
    Patel, Krish
    Kamal, Arif H.
    Lyman, Gary H.
    Peppercorn, Jeffrey M.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (03) : 845 - 850
  • [30] Current phase II and phase III clinical trials in the treatment of colorectal cancer
    Mooney, MM
    Schoenfeldt, M
    ONCOLOGY-NEW YORK, 2004, 18 (11): : 1396 - +
12345